Stock Groups

Walmart, Home Depot Rise Premarket; Tesla, Pfizer Fall -Breaking


© Reuters

Peter Nurse — Premarket Trade on Tuesday November 16th: Stocks In Focus For the latest updates, please refresh.

  • WalmartThe stock of (NYSE:) rose 0.7% following an increase in sales forecasts and profits. This retail giant anticipates strong holiday demand.

  • Tesla(NASDAQ:) Stock dropped 1.1% as Elon Musk, CEO of Elon Motors sold more shares the day before. JPMorgan Chase also filed $162 million suit against the company for breach of contract due to stock warrants this year.

  • Home Depot The stock of (NYSE:) rose 0.8% following the retailer’s quarterly sales beat. This was due to a robust housing market, which kept home improvements spending high.

  • Pfizer The stock of (NYSE:) fell 0.9% following the announcement by drugmaker that it would allow generic producers to sell its antiviral Covid-19 pills to 95 countries with low and moderate incomes.

  • Microsoft (NASDAQ:) stock rose 0.2% after Credit Suisse initiated coverage of the software giant at ‘outperform’, seeing significant growth ahead and another 19% stock price gain.

  • Southwest Airlines (NYSE:) stock fell 0.9% after Goldman Sachs downgraded its stance to ‘neutral’ from ‘buy’, citing last month’s operational problems. This influential investment bank upgraded Allegiant Travel (NASDAQ:), up 3.1%, to ‘buy’ from ‘neutral’, after it posted higher passenger traffic in October.

  • AbbVie (NYSE:) stock fell 0.2% after a report mentioned the biopharmaceutical company’s Humira rheumatoid arthritis drug as the most extreme case of drugmakers hiking prices without justification in 2020.

  • Quantumscape (NYSE:) stock fell 5.6% after Morgan Stanley downgraded its stance on the lithium battery maker to ‘equal weight’ from ‘overweight’, citing potential competition.

  • Lucid GroupStock rose 5.1% on NASDAQ after electric vehicle maker Lucid Air reported that it had more than 17,000 reservations. That’s an increase of 13,000 from the quarter before. 

  • Royalty PharmaThe stock of (NASDAQ:) rose 7.9% following the announcement that Berkshire Hathaway purchased an additional $475million stake in the drug royalty purchaser.


Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is among the most risky investment options. Please make sure you are fully aware of all the costs and risks involved.